{"sent_idx": "145", "frame_idx": "13", "ev": "No differences in mean Hb level were observed after treatment with CPD or SP.", "icos": [["0.9992501", "CPD", "CPD", "mean Hb level"], ["0.99817073", "CPD", "Sulphadoxine - pyrimethamine ( SP )", "mean Hb level"], ["0.9978083", "CPD", "sodium hydroxide", "mean Hb level"], ["0.9978034", "CPD", "AL and CPD treatment", "mean Hb level"], ["0.9977932", "CPD", "dichloromethane", "mean Hb level"]], "sample": "c"}
{"sent_idx": "179", "frame_idx": "16", "ev": "Participants whose day-7 DDS concentration was < LLOQ were younger, shorter in height and received a lower dapsone dose per kg body weight (p \u2264 0.001 for all) and were less likely to have an ACPR outcome on day-28 than those \u2265 LLOQ (104/178 (59.8%) vs. 143/174 (82.2%), p < 0.0001).", "icos": [["0.9992823", "dapsone", "DDS .", "dose"], ["0.99920183", "dapsone", "CPG", "dose"], ["0.99912125", "dapsone", "CPD", "dose"], ["0.9990963", "dapsone", "Dapsone ( DDS )", "dose"], ["0.99895287", "dapsone", "MEMSTM", "dose"]], "sample": "c"}
{"sent_idx": "179", "frame_idx": "17", "ev": "Participants whose day-7 DDS concentration was < LLOQ were younger, shorter in height and received a lower dapsone dose per kg body weight (p \u2264 0.001 for all) and were less likely to have an ACPR outcome on day-28 than those \u2265 LLOQ (104/178 (59.8%) vs. 143/174 (82.2%), p < 0.0001).", "icos": [["0.99935716", "dapsone", "DDS .", "height"], ["0.9993", "dapsone", "Dapsone ( DDS )", "height"], ["0.9991997", "dapsone", "CPG", "height"], ["0.999198", "dapsone", "CPD", "height"], ["0.99901414", "dapsone", "MEMSTM", "height"]], "sample": "c"}
{"sent_idx": "179", "frame_idx": "18", "ev": "Participants whose day-7 DDS concentration was < LLOQ were younger, shorter in height and received a lower dapsone dose per kg body weight (p \u2264 0.001 for all) and were less likely to have an ACPR outcome on day-28 than those \u2265 LLOQ (104/178 (59.8%) vs. 143/174 (82.2%), p < 0.0001).", "icos": [["0.99934226", "dapsone", "Dapsone ( DDS )", "ACPR outcome"], ["0.99925786", "dapsone", "CPD", "ACPR outcome"], ["0.999244", "dapsone", "CPG", "ACPR outcome"], ["0.9992229", "dapsone", "DDS .", "ACPR outcome"], ["0.9990571", "dapsone", "dichloromethane", "ACPR outcome"]], "sample": "c"}
{"sent_idx": "179", "frame_idx": "19", "ev": "Participants whose day-7 DDS concentration was < LLOQ were younger, shorter in height and received a lower dapsone dose per kg body weight (p \u2264 0.001 for all) and were less likely to have an ACPR outcome on day-28 than those \u2265 LLOQ (104/178 (59.8%) vs. 143/174 (82.2%), p < 0.0001).", "icos": [["0.99942386", "dapsone", "DDS .", "DDS concentration"], ["0.9994159", "dapsone", "CPD", "DDS concentration"], ["0.99939966", "dapsone", "CPG", "DDS concentration"], ["0.9993656", "dapsone", "MEMSTM", "DDS concentration"], ["0.99933535", "dapsone", "Dapsone ( DDS )", "DDS concentration"]], "sample": "c"}
